4//SEC Filing
REXAHN PHARMACEUTICALS, INC. 4
Accession 0001140361-16-072011
$IRDCIK 0001228627operating
Filed
Jul 7, 8:00 PM ET
Accepted
Jul 8, 4:44 PM ET
Size
5.5 KB
Accession
0001140361-16-072011
Insider Transaction Report
Form 4
Nolan Lisa
Chief Business Officer
Transactions
- Award
Stock Option (right to buy)
2016-07-06+1,200,000→ 1,200,000 totalExercise: $0.26Exp: 2026-07-06→ Common Stock (1,200,000 underlying)
Footnotes (1)
- [F1]One quarter of the option vests and becomes exercisable on July 6, 2017, and, thereafter, 1/36th of the remaining option vests in equal installments on the first business day of each month following such date until fully vested.
Documents
Issuer
REXAHN PHARMACEUTICALS, INC.
CIK 0001228627
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001228627
Filing Metadata
- Form type
- 4
- Filed
- Jul 7, 8:00 PM ET
- Accepted
- Jul 8, 4:44 PM ET
- Size
- 5.5 KB